The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor
- 6 December 1996
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 220 (1) , 5-8
- https://doi.org/10.1016/s0304-3940(96)13212-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanismEuropean Journal of Pharmacology, 1996
- Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in miceEuropean Neuropsychopharmacology, 1995
- Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: In vivo voltammetry studiesNeuropharmacology, 1994
- The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the ratEuropean Journal of Pharmacology, 1993
- Axonal and somato‐dendritic modalities of serotonin release: their involvement in sleep preparation, triggering and maintenanceJournal of Sleep Research, 1992
- Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the catBrain Research, 1992
- Central α1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animalsEuropean Journal of Pharmacology, 1990
- 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissueNature, 1989
- A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving catsBrain Research, 1989
- Successful treatment of idiopathic hypersomnia and narcolepsy with modafinilProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988